Cite

HARVARD Citation

    Alva, A. et al. (2017). Clinical Correlates of Benefit From Radium‐223 Therapy in Metastatic Castration Resistant Prostate Cancer. Prostate. 77 (5), pp. 479-488. [Online]. 
  
Back to record